Study prompts new ideas on cancers' origins

December 16, 2017, Washington University School of Medicine
Graduate student Megan Radyk and Jason Mills, M.D., Ph.D., led a study revealing that although many cancer therapies target rapidly dividing stem cells, mature cells also seem to play a key role in initiating cancer, at least in forming precancerous lesions. Credit: Matt Miller

Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer—a finding that could upend the way scientists think about the origin of the disease.

Researchers at Washington University School of Medicine in St. Louis have found that mature cells have the ability to revert back to behaving more like rapidly dividing stem cells. However, when old cells return to a stem cell-like status, they can carry with them all of the mutations that have accumulated to date, predisposing some of those cells to developing into precancerous lesions.

The new study is published online in the journal Gastroenterology.

"As scientists, we have focused a good deal of attention on understanding the role of stem cells in the development of cancers, but there hasn't been a focus on mature cells," said senior investigator Jason C. Mills, MD, PhD, a professor of medicine in the Division of Gastroenterology. "But it appears when mature cells return back into a rapidly dividing stem cell state, this creates problems that can lead to cancer."

The findings, in mice and in human stomach cells, also raise questions about how may evade treatment.

Most cancer therapies are aimed at halting cancer growth by stopping cells from rapidly dividing. Such treatments typically attack stem cells but would not necessarily prevent mature cells from reverting to stem cell-like status.

Cancer therapies often target cells that grow and divide rapidly, such as stem cells, but in studying how stomach cancers occur, researchers at Washington University School of Medicine in St. Louis found that even when the stomach can't make stem cells, other cells in the stomach can begin to divide and contribute to precancerous lesions. Credit: Washington University BioMed Radio

"Cancer therapies target stem cells because they divide a lot, but if mature cells are being recruited to treat injuries, then those therapies won't touch the real problem," said first author Megan Radyk, a graduate student in Mills' laboratory. "If cancer recurs, it may be because the therapy didn't hit key mature cells that take on stem cell-like behavior. That can lead to the development of and, potentially, cancer."

Studying mice with injuries to the lining of the stomach, the researchers blocked the animals' ability to call on stem cells for help in the stomach. They focused on the stomach both because Mills is co-director of Washington University's NIH-supported Digestive Disease Center and because the anatomy in the stomach makes it easier to distinguish stem cells from mature cells that perform specific tasks. Even without stem cells, the mice developed a precancerous condition because mature stomach cells reverted back to a stem cell state to heal the injury.

Analyzing tissue specimens from 10 people with stomach cancer, the researchers found evidence that those same mature cells in the stomach also had reverted to a stem cell-like state and had begun to change and divide rapidly.

The Mills lab is working now to identify drugs that may block the by preventing mature cells from proliferating and dividing.

"Knowing these cells are leading to increased cancer risk may allow us to find drugs to keep mature from starting to divide and multiply," Mills said. "That may be important in preventing not only in the and GI tract but throughout the body."

Explore further: Researchers find stomach cancer pathway doesn't work as previously thought

More information: Megan D. Radyk et al, Metaplastic Cells in the Stomach Arise, Independently of Stem Cells, via Dedifferentiation or Transdifferentiation of Chief Cells, Gastroenterology (2017). DOI: 10.1053/j.gastro.2017.11.278

Related Stories

Researchers find stomach cancer pathway doesn't work as previously thought

January 23, 2017
Conventional wisdom holds that the loss of cells that secrete acid in the stomach leads to a condition that eventually can develop into stomach cancer.

Team discovers stem cells in the esophagus

October 16, 2014
Despite previous indications to the contrary, the esophagus does have its own pool of stem cells, said researchers from the University of Pittsburgh School of Medicine in an animal study published online today in Cell Reports. ...

Source of liver stem cells identified

August 5, 2015
Howard Hughes Medical Institute (HHMI) scientists have identified stem cells in the liver that give rise to functional liver cells. The work solves a long-standing mystery about the origin of new cells in the liver, which ...

Recommended for you

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Scientists block the siren call of two aggressive cancers

January 23, 2018
Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Workouts may boost life span after breast cancer

January 22, 2018
(HealthDay)—Longer survival after breast cancer may be as simple as staying fit, new research shows.

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

mdarr
5 / 5 (3) Dec 16, 2017
But presumably the mature to stem transition is important for the healing process. So just blocking the transition will create other problems.
Also the mature to stem transition is being explored for all sorts of therapies in the heart and other organs that don't normally heal. What does this research say about the future of those therapies.
Sounds like we need to know a lot more about the healthy vs problematic stem cell issue.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.